Document ID: chunk:federal_register_of_legislation:F2023N00094:front:0
Version: federal_register_of_legislation:F2023N00094
Segment Type: other
Provision Reference: 
Character Range: 0–1418

PB 42 of 2023

National Health (Pharmaceutical Benefits) (Active Ingredient Prescribing—Excluded Pharmaceutical Benefits) Instrument 2023
I, Natasha Ploenges, Assistant Secretary, Office of Health Technology Assessment, Technology Assessment and Access Division, Department of Health and Aged Care have the authority to exclude certain pharmaceutical benefits being required to specify each drug that the pharmaceutical benefit has on a Pharmaceutical Benefits Scheme (PBS) prescription or medication chart, under Subparagraphs 40(2A)(a)(iii) and 41(2A)(a)(iv) of the National Health (Pharmaceutical Benefits) Regulations 2017 (the Regulations), as Delegate for the Secretary of the Department of Health of Aged Care.

I hereby revoke the National Health (Pharmaceutical Benefits) (Active Ingredient Prescribing—Excluded Pharmaceutical Benefits) Instrument 2 of 2021 as signed by the Assistant Secretary of the Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health on 27 August 2021. In its place, I approve this instrument.

Dated   28 April 2023

Natasha Ploenges
Assistant Secretary
Office of Health Technology Assessment
Technology Assessment and Access Division
Department of Health and Aged Care

Contents
1 Name
2 Commencement
3 Authority
4 Pharmaceutical benefits prescribed using "free text" function
5 Particular ready‑prepared pharmaceutical benefits